Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/12/2018
SIETES contiene 92610 citas

 
 
 1 a 20 de 1790 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Qato DM, Ozenberger K, Olfson M. Prevalence of prescription medications with depression as a potential adverse effect among adults in the United States. JAMA 2018;319:12 de junio. [Ref.ID 102780]
2.Enlace a cita original Cita con resumen
Bergman JEH, Lutke LR, Gans ROB, Addor M-C, Barisic I, Clavero-Carbonell C, Garne E, Gatt M, Klungsoyr K, Lelong N, Lynch C, Mokoroa O, Nelen V, Neville AJ, Pierini A, Randrianaivo H, Rißmann A, Tucker D, Wiesel A, Dolk H, Loane M, Bakker MK. Beta-blocker use in pregnancy and risk of specific congenital anomalies: A European case-malformed control study. Drug Saf 2018;41:415-27. [Ref.ID 102566]
3. Cita con resumen
Anónimo. Drugs and their names. Drug Ther Bull 2018;56:marzo. [Ref.ID 102507]
4. Cita con resumen
Tsujimoto T, Kajio H, Shapiro MF, Sugiyama T. Risk of all-cause mortality in diabetic patients taking ß-blockers. Mayo Clin Proc 2017;93:409-18. [Ref.ID 102505]
5. Cita con resumen
Alharbi FF, Souverein PC, de Groot MCH, Blom MT, de Boer A, Klungel OH, Tan HL. The impact of serum potassium-influencing antihypertensive drugs on the risk of out-of-hospital cardiac arrest: a case–control study. Br J Clin Pharmacol 2017;83:2541-8. [Ref.ID 102115]
6. Cita con resumen
Ham AC, van Dijk SC, Swart KMA, Enneman AW, van der Zwaluw NL, Brouwer-Brolsma EM, van Schoor NM, Zillikens MC, Lips P, de Groot LCPGM, Hofman A, Witkamp RF, Uitterlinden AG, Stricker BH, van der Velde N. Beta-blocker use and fall risk in older individuals: Original results from two studies with meta-analysis. Br J Clin Pharmacol 2017;83:2292-302. [Ref.ID 102082]
7. Cita con resumen
Dimmitt S, Stampfer H, Martin JH. When less is more – Efficacy with less toxicity at the ED50. Br J Clin Pharmacol 2017;83:1365-8. [Ref.ID 101984]
8. Cita con resumen
Nair NP, Chalmers L, Bereznicki BJ, Curtain C, Peterson GM, Connolly M, Bereznicki LR. Adverse drug reaction-related hospitalizations in elderly Australians: a prospective cross-sectional study in two Tasmanian hospitals. Drug Saf 2017;40:597-606. [Ref.ID 101969]
9. Cita con resumen
Perreault S, de Denus S, White M, White-Guay B, Bouvier M, Dorais M, Dubé M-P, Rouleau J-L, Tardif J-C, Jenna S, Haibe-Kains B, Leduc R, Deblois D. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality. Pharmacoepidemiol Drug Saf 2017;26:81-90. [Ref.ID 101948]
10. Cita con resumen
Anónimo. Beta blockers and the risk of CV events in type 2 diabetes. Diabetes in Control 2017:29 de julio. [Ref.ID 101936]
11. Cita con resumen
Hodges NL, Spiller HA, Casavant MJ, Chounthirath T, Smith GA. Non-health care facility medication errors resulting in serious medical outcomes. Clinical Toxicology 2017:1-8. [Ref.ID 101917]
12. Cita con resumen
Duan L, Ng A, Chen W, Spencer HT, Nguyen J, Shen AY-J, Lee M-S. ß-blocker exposure in pregnancy and risk of fetal cardiac anomalies. JAMA Intern Med 2017;177:885-7. [Ref.ID 101621]
13. Cita con resumen
Dondo TB, Hall M, West RM, Jemberg T, Lindahl B, Bueno H, Danchin N. ß-blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction. J Am Coll Cardiol 2017;69:2710-20. [Ref.ID 101613]
14. Cita con resumen
Greenway T, Ross JS. US drug marketing: how does promotion correspond with health value?. BMJ 2017;357:j1855. [Ref.ID 101571]
15. Cita con resumen
Anónimo. Drugs for hypertension. The Medical Letter on Drug and Therapeutics Bulletin 2017;59:41-8. [Ref.ID 101527]
16. Cita con resumen
Anónimo. Femmes enceintes atteintes d'une maladie de Basedow. Prescrire 2017;37:193-8. [Ref.ID 101458]
17. Cita con resumen
Anónimo. Spironolactone - potion or poison?. Drug Ther Bull 2017;55:13. [Ref.ID 101402]
18. Cita con resumen
Anónimo. Maladie de Basedow chez les adultes. Prescrire 2016;36:833-40. [Ref.ID 100952]
19. Cita con resumen
Anónimo. Chutes et médicaments. Prescrire 2016;36:825. [Ref.ID 100951]
20. Cita con resumen
Puymirat E, Riant E, Aissoui N, Soria A, Ducrocq G, Coste P, Cottin Y, Aupetit JF, Bonnefoy E, Blanchard D, Cattan S, Steg G, Schiele F, Ferrières J, Juillière Y, Simon T, Danchin N. ß blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study. BMJ 2016;354:i4801. [Ref.ID 100677]
Seleccionar todas
 
 1 a 20 de 1790 siguiente >>